Loading company details...
Beta
Latest Form 4 (Oct 14, 2026): Thomas Kosasa (Director): Purchase of 129,758 shares, $750.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Thomas Kosasa | Purchase | 129,758 | $750.0K |
| Oct 14, 2026 | Jeffrey Yu, Chief Medical Officer | Purchase | 45,126 | $250.0K |
| Oct 10, 2026 | Robert Lawrence Golden, Chief Financial Officer | Grant/Award | 10,000 | n/a |
| Oct 10, 2026 | Aaron Green, Chief Executive Officer | Grant/Award | 65,000 | n/a |
| Sep 15, 2026 | Jeffrey Yu, Chief Medical Officer | Purchase | 142,857 | $90.0K |
| Aug 7, 2026 | Thomas Kosasa | Purchase | 1,449,275 | $1000.0K |
| Jun 24, 2026 | Aaron Green, Chief Executive Officer | Purchase | 36,650 | $21.0K |
| Jun 24, 2026 | Jeffrey Yu, Chief Medical Officer | Purchase | 158,730 | $100.0K |
| Jun 17, 2026 | Jeffrey Yu, Chief Medical Officer | Purchase | 172,414 | $100.0K |
| Jun 16, 2026 | Aaron Green, Chief Executive Officer | Purchase | 36,920 | $20.6K |